Insights from 2023 ESMO Asia Annual Meeting

 

Insights from 2023 ESMO Asia Annual Meeting
S

Leveraging the Molecular Biology of HCC in Optimising Response to Immunotherapy

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Stephen L. Chan
By Insights from 2023 ESMO Asia Annual Meeting FEATURING Stephen L. Chan
38 views
January 24, 2024
0 Comments
Login to view comments. Click here to Login
Gastrointestinal
18:31

Enhancing IO Benefit in Upper-Aerodigestive Malignancies - Leveragin…

Insights from 2023 ESMO Asia Annual Meeting

B. Henick

114 views
08:19

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Ol…

Insights from 2023 ESMO Asia Annual Meeting

E. Oki

34 views
08:21

ESMO Asia 2023 Insights: "IMbrave150 Trial - Exploratory Analyses fo…

Insights from 2023 ESMO Asia Annual Meeting

M. Kudo

60 views
11:13

Leveraging the Molecular Biology of HCC in Optimising Response to Im…

Insights from 2023 ESMO Asia Annual Meeting

S. L. Chan

38 views
06:49

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy in HCC…

Insights from 2023 ESMO Asia Annual Meeting

M. Persano

71 views
06:53

ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors of Act…

Insights from 2023 ESMO Asia Annual Meeting

M. Persano

41 views
06:05

ESMO Asia 2023 Insights: "Long-Term Outcomes of Intraoperative Chemo…

Insights from 2023 ESMO Asia Annual Meeting

J. Taieb

131 views
21:46

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management…

Insights from 2023 ESMO Asia Annual Meeting

M. Ikeda

305 views
18:15

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

173 views
08:56

ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuzumab …

Insights from 2023 ESMO Asia Annual Meeting

S. Rha

136 views
13:51

ESMO Asia 2023 Insights: "Final Results of the RATIONALE-305 Study -…

Insights from 2023 ESMO Asia Annual Meeting

K. Kato

131 views